Effects of losartan on the sexual behavior of male rats

Pharmacology

Volumn 58, Issue 3, 1999, Pages 132-139

  Chan, Paul ^a   Liu, Ju Chi ^a   Tong, Yat Ching ^b   Chen, Yi Jen ^a   Wang, Chia Chen ^b   Tomlinson, Brian ^c   Cheng, Juei Tang ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c National Cheng Hung University ^*

Author keywords

Angiotensin II; Hypertension; Impotence; Losartan; Sexual function

Indexed keywords

LOSARTAN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EJACULATION; ERECTILE DYSFUNCTION; FEMALE; HYPERTENSION; INTRAGASTRIC DRUG ADMINISTRATION; LATENT PERIOD; LIBIDO; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; SEXUAL FUNCTION; VIDEORECORDING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EJACULATION; FEMALE; LOSARTAN; MALE; PROPRANOLOL; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SEXUAL BEHAVIOR, ANIMAL;

EID: 0032898340     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028275     Document Type: Article

References (38)

1. Joint National Committee on Detection, Evaluation, and Treatment High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of high blood pressure (JNC V): Arch Intern Med 1993; 5(suppl II):97-102.
2. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148:1023-1038.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke and coronary heart disease. 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
5. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet 1981;ii:539-543.
6. Jachuck SJ, Brierley H, Jachuck S, Willcox PM: The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1982;32:103-105.
7. Bulpitt CJ: Quality of life in antihypertensive patients; in Amery A (ed): Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Boston, Kluver, 1982, pp 929-948.
8. Najman JM, Levine S: Evaluating the impact of medical care and technologies on the quality of life: A review and critique. Soc Sci Med [F] 1981;15:107-115.
9. Linden W: Psychological perspectives of essential hypertension: Etiology, maintenance and treatment. Basel, Karger, 1984.
10. Smith PJ, Talbert RL: Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm 1984;18:113-121.
11. Stevenson JG, Umstead GS: Sexual dysfunction due to antihypertensive agents. Drug Intell Clin Pharm 1984;18:113-121.
12. Trimmer E: Sex problems in practice. Iatrogenic sex problems. Br Med J [Clin Res] 1981;283:953-955.
13. Papadopoulos C: Cardiovascular drugs and sexuality: A cardiologist's review. Arch Intern Med 1980;140: 1341-1345.
14. Buffum J: Pharmacosexology update: Prescription drugs and sexual function. J Psychoactive Drugs 1986;18:97-106.
15. Moss HB, Procci WR: Sexual dysfunction associated with oral antihypertensive medication: A critical survey of the literature. Gen Hosp Psychiatry 1982;4:121-129.
16. Croog SH, Levine S, Sudilovsky A, Baume RM, Clive J: Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. Arch Intern Med 1988; 148:788-794.
17. Timmermans PBMWM, Chiu AT, Herblin WF, Wong PC, Smith RD: Angiotensin II receptor subtypes. Am J Hypertens 1992;5:406-410.
18. Burson JN, Aguilera G, Gross KW, Sigmund CD: Differential expression of angiotensin receptor IA and IB in mouse. Am J Physiol 1994; 267:E260-E267.
19. Chiu AT, McCall DE, Price WA: Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of losartan, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990; 252:711-718.
20. Wong PC, Price WAJr, Chiu AT: Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of Exp 3174: An active metabolite of losartan, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;255:211-217.
21. Prisant LM, Carr AA, Bottini PB, Solursh DS, Solursh LP: Sexual dysfunction with antihypertensive drugs. Arch Intern Med 1994;154: 730-736.
22. Tong YC, Hung YC, Lin SN, Cheng JT: Dark-cycle video surveillance of sexual performances of normal and diabetic rats. Urol Int 1996;56:207-210.
23. Dewsbury DA: A quantitative description of the behavior of rats during copulation. Brain Res 1966;15: 154-160.
24. Tong YC, Hung YC, Lin SN, Cheng JT: Treatment effect of 'Ryu-Wei-Ti-Huang-Wan' (a Chinese herbal prescription) on the sexual performance of male rats with streptozotocin-induced diabetes. Urol Int 1996; 57:230-234.
25. Weiss RJ: Effects of antihypertensive agents on sexual function. Am Fam Physician 1991;44:2075-2082.
26. Williams GH, Croog SH, Levine S, Testa MA, Sudilovsky A: Impact of antihypertensive therapy on quality of life: Effect of hydrochlorothiazide. J Hypertens 1987;5(suppl): S29-S35.
27. Semmens JP, Semmens FJ: Inadequate vaginal lubrication. Med Aspects Hum Sex 1978;12:58-71.
28. Spark RF, Melby JC: Aldosteronism in hypertension. The spironolactone response test. Ann Intern Med 1968; 69:685-691.
29. Burnett WC, Chahine RA: Sexual dysfunction as complication of propranolol therapy in men. Cardiovasc Med 1979;4:811-815.
30. Warren SC, Warren SG: Propranolol and sexual impotence [letter]. Ann Intern Med 1978;88:716-717.
31. Riley AJ, Riley EJ, Davies HJ: A method for monitoring drug effects on male sexual response: The effect of single-dose labetalol. Br J Clin Pharmacol 1982;14:695-700.
32. Law MR, Copland RF, Armitstead JG, Gabriel R: Labetalol and priapism [letter]. Br Med J 1980;280: 115.
33. Clonidine (Catapres) and other drugs causing sexual dysfunction. Med Lett Drugs Ther 1977;19:81-82.
34. Impotence: National Institutes of Health Consensus Statement 1992; 10:1.
35. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
36. Muller SC, Damanhoury H, Ruth J, Lue TF: Hypertension and impotence. Eur Urol 1991;19:29-34.
37. Tong YC, Hung YC, Lin SC, Cheng JT: The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Auton Nerv Syst 1996;56: 215-218.
38. Modebe O: Erectile failure among medical clinic patients. Afr J Med Sci 1990;19:259-264.